Although it has long been demonstrated that anti-NA antibodies reduce influenza viral replication, transmission, and pathology in animals as well as viral shedding and clinical disease in human studies, influenza vaccine research efforts have for many decades focused on immunity against HA [14,15]. The gene discussed is XK; the disease is influenza.